Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

[News] Targeting the B-cell signalling pathway in CLL and MCL

20:41 EDT 27 Jun 2013 | The Lancet

A new class of drugs that inhibit the B-cell signalling pathway could represent a turning point in the treatment of chronic lymphocytic leukaemia and mantle cell lymphoma. Ibrutinib is an oral inhibitor of the Bruton's tyrosine kinase, which is thoug...

Original Article: [News] Targeting the B-cell signalling pathway in CLL and MCL

NEXT ARTICLE

More From BioPortfolio on "[News] Targeting the B-cell signalling pathway in CLL and MCL"

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Story